Trial Profile

Clinical Trials Insight: 700040591

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Jun 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tesetaxel (Primary)
Indications Cancer; Gastrointestinal stromal tumours; Nasopharyngeal cancer; Solid tumours; Uterine cancer
Focus Adverse reactions; Pharmacokinetics
Sponsors Genta

Most Recent Events

11 Jun 2010 According to an ASCO abstract, twenty-six patients have been treated to date, and accrual is continuing.
07 Jun 2010 Results presented at the ASCO 2010, according to a Genta media release.
26 Feb 2010 Status changed from recruiting to completed, according to a Genta media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com